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ABSTRACT  
 
Rationale:  Adequate microcirculatory perfusion, and not just opening of occluded arteries, 
is critical to salvage heart tissue following myocardial infarction (MI).  However, the degree of 
microvascular perfusion taking place is not known, limited primarily by an inability to directly 
image coronary microcirculation in a beating heart in vivo.  Haematopoietic stem/progenitor 
cells (HSPCs) offer a potential therapy but little is known about their homing dynamics at a 
cellular level and whether they protect coronary microvessels.  This study used intravital 
microscopy (IVM) to image the anaesthetised mouse beating heart microcirculation following 
stabilisation. 
Methods/Results:  A 3D-printed stabiliser was attached to the ischaemia-reperfusion 
injured (IRI) beating heart.  The kinetics of neutrophil, platelet and HSPC recruitment, as well 
as functional capillary density (FCD), was imaged post-reperfusion. Laser speckle contrast 
imaging (LSCI) was used for the first time to monitor ventricular blood flow in beating hearts. 
Sustained hyperaemic responses were measured throughout reperfusion, initially indicating 
adequate flow resumption.  IVM confirmed large vessel perfusion but demonstrated poor 
transmission of flow to downstream coronary microvessels.  Significant neutrophil adhesion 
and microthrombus formation occurred within capillaries with the latter occluding them, 
resulting in patchy perfusion and reduced FCD. Interestingly, „patrolling‟ neutrophils were 
also observed in capillaries.  HSPCs readily trafficked through the heart but local retention  
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of 
Cardiology.  
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
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was poor. Despite this, remarkable anti-thromboinflammatory effects were observed, 
consequently improving microvascular perfusion.  
Conclusion: We present a novel approach for imaging multiple microcirculatory 
perturbations in the beating heart with LSCI assessment of blood flow.  Despite deceptive 
hyperaemic responses, increased microcirculatory flow heterogeneity was seen, with non-
perfused areas interspersed with perfused areas.  Microthrombi, rather than neutrophils, 
appeared to be the major causative factor.  We further applied this technique to demonstrate 
local stem cell presence is not a pre-requisite to confer vasculoprotection. This is the first 
detailed in vivo characterisation of coronary microcirculatory responses post-reperfusion 
injury.   
 
Key words – coronary microcirculation, ischaemia-reperfusion injury, intravital microscopy  
 
 
 
INTRODUCTION 
 
Treatment of myocardial infarction (MI) focuses on rapidly re-establishing reperfusion 
following blockage in one or more of the coronary arteries.  Despite successful thrombolytic 
and primary percutaneous coronary interventions (PCI), a significant proportion of patients 
still incur muscle damage and proceed to develop heart failure.1-2  Indeed, restoration of 
normal epicardial blood vessel flow following PCI, but with sub-optimal myocardial perfusion, 
can be observed in as high as 50% of patients.3-4 This is strongly associated with larger 
infarcts, reduced ventricular function and overall worse outcomes than in patients with full 
perfusion recovery.5-6  It is likely that in the absence of overt atherosclerotic disease or 
occlusions within larger and clinically visible conduit vessels, tissue damage occurs 
subsequent to inadequate coronary microcirculatory perfusion. Indeed, in recent years, 
cardiovascular magnetic resonance (CMR) imaging has provided new insights into the 
significant impact microvascular obstruction and intramyocardial haemorrhage has on 
clinical outcomes.7  Furthermore, progressive loss of distal perfusion at the tissue level and 
neutrophil accumulation has been demonstrated in patients post-MI using PET scanning.8 
However, current clinical imaging tools such as x-ray angiography, CMR and PET cannot 
spatially resolve blood vessels less than 200μm in diameter and so are unable to image 
small capillaries nor the blood cells within them at a cellular level. 
An inability to directly image microvessels of the heart has led to cardiologists focussing their 
efforts on improving flow within the angiographically visible part of the coronary circulation. 
This has prevented a complete identification of the role of the microcirculation in ischaemic 
cardiovascular disease.  The microcirculation comprises the functional „business‟ end of the 
circulation and, in the heart, is responsible for 75% of myocardial blood flow. The significant 
oxygen demand of the heart is provided by an extensive dense network of capillaries running 
between all muscle fibres providing almost every fibre with its own capillary. The 
microvasculature controls total coronary resistance and is thus critical in regulating 
myocardial blood flow.  Moreover, it is highly responsive to, and a vital participant in, the 
inflammatory response.  Dysfunction of the coronary microvasculature has recently emerged 
as a potentially important mechanism contributing to MI with important prognostic 
implications.  Indeed, an increasing number of publications have emphasised the need to 
focus research interests into studying the coronary microcirculation from both a basic and 
clinical perspective and prevent it remaining as a research „black box‟.9-12  The importance of 
the microcirculation in heart disease is further exemplified in conditions such as 
microvascular angina (cardiac syndrome X) and in MI with non-obstructive coronary arteries 
(MINOCA) where patients present with the clinical features of an acute MI but without 
angiographic evidence of obstructive coronary arteries. 12-14 
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Currently, little is known about the full range of microcirculatory responses to MI in vivo, 
limited primarily by an inability to directly image these events in a beating heart.   Functional 
readouts, such as blood flow and pressure, can be determined clinically using a Doppler flow 
wire inserted into the coronary artery or assessed using thrombolysis in MI (TIMI) flow or 
myocardial blush.  However, these assessments are mainly of larger vessels and actual 
visualisation of coronary microcirculation, let alone any detrimental events taking place 
within them, remains impossible with current clinical imaging  tools.  Experimental 
knowledge to date has commonly been obtained histologically, but these static snapshots 
provide no indication of the real-time kinetics of inflammatory cell recruitment - a dynamic 
process - in the presence of pathophysiological flow.  Tissue sections also do not offer any 
information on microvessel integrity and perfusion. Consequently, experts have recently 
suggested creating an international “coronary microcirculatory observatory”, a virtual facility 
utilising imaging techniques such as intravital microscopy (IVM) to properly interrogate the 
coronary microcirculation in the beating heart of living animals.11   
However, real-time microscopic imaging of the beating heart has been very challenging as 
motion compromises spatial and temporal resolution and therefore requires „stabilisation‟ of 
the heart – this in itself is technically very difficult.  We have developed a stabilisation 
method that sufficiently reduces motion in a small region of the beating left ventricle to permit 
intravital imaging of the coronary microcirculation.  Li and colleagues have used a somewhat 
similar approach to monitor dynamic neutrophil events in a donor beating heart transplanted 
in the neck of a recipient.15  However, we present further novel data illustrating the extensive 
nature of neutrophil and platelet adhesion that occurs in the microcirculation following 
myocardial ischaemia-reperfusion injury (IRI) in a native heart in situ.  In particular, we show 
platelet microthrombi occluding significant lengths of the capillaries and the considerable 
detrimental impact of these occlusions on functional capillary density (FCD).  Furthermore, 
we combine IVM with full field laser speckle contrast microscopy to correlate microvascular 
events with whole beating heart blood perfusion.  Importantly we show poor microcirculatory 
perfusion is observed intravitally despite an overall reactive hyperaemic response detected 
using laser speckle imaging.  Increased clinical recognition of the importance of the coronary 
microcirculation has meant identifying strategies to improve detrimental perturbations within 
it has also gained recent attention.  To this effect, we also investigated the homing of 
systemically delivered exogenous bone marrow (BM)-derived haematopoietic 
stem/progenitor cells (HSPCs) to the injured heart.  This is the first study to directly image, at 
a cellular level, the myocardial homing and trafficking of any exogenous stem cell type in 
vivo.  We demonstrate their remarkable ability to confer vasculoprotection, and have 
elucidated potential therapeutic mechanisms of action, which occurs despite limited 
interactions with the coronary microcirculation and poor myocardial retention.    
 
METHODS 
 
Myocardial IR injury  
Experiments were conducted on male C57BL/6 mice (8-12 weeks) in accordance with the 
Animals (Scientific Procedures) Act of 1986 (ASPA) which enforces Directive 2010/63/EU of 
the European Parliament on the protection of animals used for scientific purposes (Project 
licence: P552D4447). We have previously reported the microcirculatory response to IRI, and 
HSPC trafficking, within the liver, gut and kidney of male mice.  In order to make meaningful 
comparisons between these events in different vascular beds, the current work was also 
performed in male mice.  Anaesthesia was induced by I.P. administration of ketamine 
hydrochloride (100mg/kg) and medetomidine hydrochloride (100mg/kg) and maintained as 
required via intra-arterial administration.  Mice were intubated and ventilated with medical 
oxygen via a MiniVent rodent ventilator (stroke volume: 220μl, respiratory rate: 130pm; 
Biochrom Ltd. Harvard Apparatus, UK).  The carotid artery was cannulated to facilitate 
infusion of fluorescently labelled cells, antibodies, dyes and maintenance anaesthetic. IRI 
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was induced by ligating the left anterior descending (LAD) artery for 45mins with reperfusion 
initiated for 2hrs by removal of the suture. 
 
Haematopoietic stem / progenitor cells – HPC-7 cells 
Intravital studies monitoring HSPC trafficking have been limited due to difficulties in isolating 
sufficient numbers for in vivo experimentation.  Therefore, an immortalised HSPC line, HPC-
7, was used. These cells have characteristics similar to primary cells including surface 
expression of common murine HSC markers (c-kit+, CD34-, Lin-) and surface adhesion 
molecules and are also able to reconstitute haematopoiesis when injected into lethally 
irradiated hosts.16  We have previously used HPC-7s to model hepatic and intestinal HSPC 
recruitment.17-20  To image HPC-7s, they were labelled with 5µM carboxyfluorescein 
diacetate succinimidyl ester (CFDA-SE; Life Technologies, UK) as previously described.17-20  
To assess whether their adhesion could be enhanced in the heart  in vivo, HPC-7s were pre-
treated with hydrogen peroxide (H2O2, 100μM; 1hr) prior to infusion.  This strategy has 
previously been used by us to successfully enhance HSPC retention in the gut.18 
Characterising injury on coronary endothelium and myocytes using flow cytometry 
Flow cytometry on digested heart cells was developed to determine whether coronary 
microvasculature was more susceptible to IRI than myocytes and whether HSPCs could 
modify inflammatory and oxidative injury.  Ventricles were mechanically digested using 
collagenase type-I dispersion solution (0.1%; Wako Chemicals, Japan) and strained through 
a 70μm filter into media (DMEM, 10% FCS, 1% penicillin/streptomycin; Sigma).  Cells were 
isolated by centrifugation, fixed, permeablised with 70% ethanol and then re-suspended in 
blocking agent (rat anti-mouse CD16/32 antibody; BioLegend).  Washed cells were 
incubated with antibodies as required: PE-conjugated rat anti-mouse CD31 (dilution 1:50; 
390; ThermoFisher Scientific), PE-conjugated rat IgG2a control (dilution 1:50; eBR2a; 
ThermoFisher Scientific), PE-conjugated human anti-mouse/human/rat cardiac Troponin-T 
(cTnT; dilution 1:10; REA400; Miltenyi Biotec), Alexa 488 conjugated rat anti-mouse ICAM-1 
(1:50), PE-Cy7 anti-mouse VCAM-1 (1:50), PE-conjugated human REA control (dilution 
1:10; REA293; Miltenyi Biotec), purified polyclonal goat anti-8-OHdG (dilution 1:500; 
Abcam), purified goat IgG control (dilution 1:500, Abcam). Data analysis was performed on 
washed cells using FACSCalibur (BD Biosciences). Adhesion molecule expression and 
oxidative damage on cTnT+ myocytes and CD31+ ECs was quantitated in 30,000 cellular 
events and expressed as mean fluorescence intensity. 
 
8-OHdG and DHE staining of vena cava endothelial cells in vitro 
The ability of HSPCs to modify oxidative damage or limit the generation of superoxide 
species within cardiovascular endothelial cells (EC) following ROS challenge was assessed 
in vitro.  Immortomouse derived vena cava ECs (VCEC)17 were grown to confluence and 
then exposed to H2O2 (100M) to oxidatively damage them for 24 or 72 hrs in the presence 
or absence of 5x104 HSPCs.  To assess oxidative damage, ethanol fixed and permeabilised 
VCECs were incubated with a polyclonal goat anti-mouse 8-OHdG antibody (dilution 1:500) 
followed by Alexa 488-conjugated donkey anti-goat IgG antibody (dilution 1:250).  
Dihydroethidium (DHE; 500μl; 10μM) was added to detect superoxide generation. Cells were 
imaged using EVOS and integrated density was calculated for 8-OHdG and DHE. 
 
Intravital imaging of the cardiac microcirculation 
To facilitate intravital visualisation of epicardial microcirculation in the anaesthetised mouse 
beating heart, we modified a stabiliser previously described by Lee and colleagues.21  A 
small 3D-printed ring, with internal and external diameters of 2.25mm and 4mm respectively, 
was lowered onto the left ventricle using a micromanipulator.  It was permanently fixed to the 
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heart using a thin layer of clinical grade Vetbond (3M UK plc, Bracknell, UK) on its 
underside.  This sufficiently reduced motion of a small region of the ventricle to allow 
imaging within its centre whilst the rest of heart continued to beat normally.  No BP/HR 
changes were identified as a result of this process as determined by photoplethysmograghy 
(Supplementary Figure 1).  The central area was kept moist by application of 0.9% saline 
with the surrounding area covered with saran wrap to prevent loss of moisture. In IRI hearts, 
application of the stabiliser was initiated five minutes after the LAD artery was unclamped 
and downstream of the ligation site (area most at risk of infarction).  The same region was 
identified in sham hearts.  Intravital imaging was performed using a Nipkow spinning disk 
confocal head attached to an upright Olympus BX61WI microscope with an Evolve EMCCD 
camera (Photometrics, USA).  Since it took 20-30mins before the mouse was ready for 
imaging, the first recording lasting 2min took place from a pre-selected field of view at 30 
mins post-reperfusion. Subsequent 2min recordings were made from the same area every 
15 mins for 2hrs.  All data was captured, stored and analysed using Slidebook 6 software 
(Intelligent Imaging Innovations, USA).    
 
To image endogenous neutrophils and platelets in the same mouse, 20μl of PE-conjugated 
rat anti-mouse Gr-1 antibody (RB6-8C5; Thermofisher) and an APC-conjugated rat anti-
mouse CD41 antibody (MWReg30, Thermofisher) were both administered 5mins prior to 
ischaemia.  Platelet aggregates/microthrombi were quantitated by placing a mask around 
CD41 positive areas and integrated fluorescence density, which took into account size and 
flourescence intensity, was calculated.  Considering the sheer numbers of endogenous 
platelets, labelling all of them made it difficult to quantitate singular platelet events.  
Therefore, in separate mice, 1x108 CFSE-labelled donor platelets were systemically injected.  
This results in a labelled fraction in the recipient of 5% of all circulating platelets, a value 
low enough to allow individual platelets to be imaged.  To investigate the kinetics of HSPC 
homing to the heart, 100L of 2x106 CFSE-labelled HSPCs were injected at 30min post-
reperfusion.  This time point enabled stabiliser attachment, mouse transfer to the microscope 
and HSPC „first-pass‟ to be imaged.  However, to assess potential vasculoprotective effects, 
HSPCs were injected within 5mins of reperfusion.  Neutrophils, platelets and HSPCs were 
manually counted and considered adherent if they remained static for >30 seconds.  Free 
flowing cells were identified as those that passed through the coronary microcirculation 
without making adhesive interactions. To identify areas of perfused blood vessels, 100μl of 
FITC-BSA (Sigma, UK) was administered at 2hrs post-reperfusion.  All intravital data was 
analysed by an independent blinded observer.  At the end of experimentation, mice were 
culled by cervical dislocation.   
 
Laser speckle contrast imaging (LSCI) of the beating mouse heart 
LSCI was utilised to quantitate left ventricular myocardial blood flow.  Mice were surgically 
prepared as described earlier but no stabiliser was attached. An LSCI device (moorFLPI-2; 
Moor Instruments, UK) was positioned above the exposed heart.  A demarked area, typically 
downstream of the LAD ligation site, was identified for collection of flux data during pre-
ischaemia, ischaemia and at every 15mins post-reperfusion.  A total number of 1000 frames 
were captured at each time point using the manufacturer supplied image software 
(mFLPI2Measure V2.0; mFLPIReview V5.0) at a frame rate of 25Hz and using spatial 
processing (sliding window, time constant: 0.1s). Basic Speckle Analysis software (SpAn), 
written in-house (available on request), allowed identification and collation of flux values 
during diastole for each time point (Supplementary Figure 2).   
 
Measurement of serum inflammatory cytokine concentrations 
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Circulating cytokine concentrations were identified in serum samples from mice following 
sham surgery, IRI, or IRI+HSPC administration within 5 minutes of reperfusion. Reperfusion 
was performed for 1hr.  Serum was isolated by centrifugation (2,000rpm, 10 mins). Samples 
were loaded in triplicate onto a Bio-Plex pro mouse cytokine 23-plex assay plate (Bio-Rad 
Laboratories, CA, US) and analysed using a Luminex 200 plate reader (Bio-Rad 
Laboratories, CA, US) following the manufacturer‟s instructions.  
 
Statistical analysis 
All statistical analysis was performed using Graphpad Software (GraphPad Software, Inc., 
USA). Direct comparisons between two groups were performed using a Student t-test. 
Comparisons between three or more groups were performed by one-way ANOVA, followed 
by Sidak post-hoc tests. For time course studies, such as neutrophil recruitment over time, 
comparisons were made by two-way ANOVA, followed by Sidak post-hoc tests for individual 
time points. All data is presented as mean±SEM. 
 
 
RESULTS 
 
Neutrophil recruitment and platelet microthrombus formation increases rapidly 
following myocardial IRI   
The number of neutrophils freely circulating through coronary microcirculation increased at 
all time points post-reperfusion when compared to sham hearts, but this did not attain 
statistical significance (Fig.1A). Interestingly, numbers of adherent neutrophils within sham 
hearts was high with 60-70 cells observed per field of view.  However, this more than 
doubled following IRI and remained significantly (p<0.0001) elevated (Fig.1B&F). No 
change in the number of individual, free flowing platetets occurred as a result of injury 
(Fig.1C). Unlike neutrophils, their adhesion within sham hearts was minimal, but significantly 
(p<0.01) increased following injury (Fig.1D).  IRI also led to the striking and significant 
(p<0.001) formation of numerous platelet aggregates and microthrombi within coronary 
capillaries which was sustained throughout the duration of the experiment (Fig.1E&F).  No 
such aggregates were identified in sham hearts.   
  
Adherent neutrophils do not compromise blood flow unlike platelet microthrombi  
Since significant adherent neutrophils were observed in sham hearts, it was possible that the 
process of placing the stabiliser induced a local inflammatory response.  Therefore, sham 
experiments were conducted mice in which the beating heart was imaged in the absence of 
the stabiliser.  Although images were difficult to obtain, blurry and relatively out-of-focus, 
adherent neutrophils were still present in similar numbers to those seen in stabilised hearts 
(Fig.2A). They did not compromise blood flow as evidenced by FITC-BSA perfused 
capillaries being visible in the whole field of view (Fig.2B&3A). IRI induced a marked and 
significant increase in individual neutrophil adhesion, although neutrophil clusters were also 
identified (Fig.2C).  Blood flow was compromised in IRI hearts as evidenced by a failure of 
some capillaries to load with FITC-BSA (Fig.2D&3B). Interestingly, these areas did not 
correspond with neutrophil adhesion, but rather predominantly matched areas in which 
striking adherent platelet aggregates and microthrombi were identified. These were  
occlusive and often identified upstream of areas in which no FITC-BSA was observed 
(Fig.2D&E).  Microthrombi were not generally observed in the larger vessels but formed 
primarily within coronary capillaries often occupying significant lengths of vessel.  Numerous 
smaller and more rounded platelet aggregates were also found dispersed within the field of 
view.  Aggregates were often, but not always, comprised of both neutrophils and platelets. 
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These aggregates appeared to occassionaly „block‟ the circulation of trafficking neutrophils 
(Fig.2F). Although adherent neutrophils appeared at first glance to be completely stationary, 
detailed analysis of videos demonstrated that some neutrophils, in both sham and IRI hearts, 
were actually moving short distances or „patrolling‟ the length of the capillary (Fig.2G). 
 
Myocardial IRI is associated with impaired capillary perfusion  
An extensive network of FITC-BSA perfused capillaries was observed in sham mice, 
paralleling the arrangement of muscle fibres, with cross connections along their length.  
Focussing up and down on the field of view showed no areas devoid of perfused capillaries.  
Well perfused medium-sized vessels were also visible in some fields of view (Fig.3A).  In 
contrast, IRI was associated with multiple areas in which FITC-BSA did not perfuse. This 
resulted in patchy areas that appeared devoid of any microvasculature, indicating poor FCD. 
Indeed, in some fields of view, up to half the imaged area appeared non-perfused.  
Furthermore, the structured parallel arrangement of capillaries was lost with the 
microvasculature appearing more disorganised.  Accumulation of FITC-BSA, identified as 
slightly wider vascular areas of intense fluorescence, was also seen along the length of 
some capillaries.  Interestingly, medium sized vessels were still readily visible and well 
perfused in injured hearts (Fig.3B). 
 
Despite poor HSPC retention within injured hearts, significant vasculoprotective 
effects are identified 
Approximately 20-30 free flowing HSPCs were identified at all time points in sham mice.  
However, in IRI hearts, this number increased almost 4-fold at 30mins post-reperfusion (the 
first time point after infusion). At all other time points, although circulating HSPC numbers 
remained elevated, the effect was not as remarkable.  H2O2 pre-treatment did not enhance 
HSPC homing to the injured heart. (Fig.4A).  Adhesion was low and did not differ between 
IRI and sham hearts nor with pre-treatment (Fig.4B-C).  HSPC infusion did not affect 
circulating neutrophil numbers but did remarkably and significantly decrease neutrophil 
(p<0.0001) and platelet (p<0.001) adhesive events in IRI hearts (Fig.4D-G).  This resulted in 
clear improvements in capillary FITC-BSA perfusion (Fig.4H).  Since H2O2 did not influence 
HSPC homing, the vasculoprotective effects of pre-treated cells was not tested. 
 
Myocardial IRI induced a sustained ventricular hyperaemic response 
Left ventricular diastolic and systolic events were easily detected on flux analysis recordings 
as high and low points respectively.  We focussed on diastolic events for comparative 
purposes (Fig.5A).  In sham mice, blood flow did not change throughout the course of 
imaging.  As expected, ischaemia reduced flow with arbitrary flux values decreasing from 
1700 to 1400.  Reperfusion was associated with a significant (p<0.001) and sustained 
reactive hyperaemic response with values increasing to 2000 (Fig.5B). The presence of 
HSPCs in IRI hearts produced blood flow flux recordings that were statistically (p<0.05) 
different to sham hearts but did not differ from IRI hearts not receiving HSPCs.   
 
Myocardial endothelial cells are more susceptible to oxidative stress than 
cardiomyocytes following acute IRI but this injury can be reduced by HSPCs 
Digested whole heart cells were examined using flow cytometry and CD31+ ECs and CTnT+ 
myocytes identified (Fig.6A). The percentage of myocytes recovered from the sampled 
population of cardiac cells was consistently higher (80%) than the yield of ECs (10%) 
across all groups of mice (Fig.6B).  Compared to sham controls, ICAM-1 expression on ECs 
was significantly increased during ischaemia (p<0.05) and reperfusion (p<0.01). This 
increase was reduced in mice receiving HSPCs when compared to IRI mice not receiving 
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cellular therapy (Fig.6C).  Interestingly, VCAM-1 and oxidative stress (p<0.01) only 
increased during reperfusion with both returning to baseline values in mice receiving HSPCs 
(Fig.6D&E). Although there was a trend for myocytes to also undergo oxidative damage 
following injury, this did not reach statistical significance. Furthermore, only 1-2% of 
myocytes presented with oxidative damage compared to 30% of ECs (Fig.6F). 
 
Microvascular endothelial oxidative stress can be reduced in the presence of HSPCs 
in vitro 
The ability of HSPCs to decrease oxidative stress, specifically in cardiovascular ECs in vitro, 
was tested in a co-culture system using VCECs. Oxidative damage resulting from H2O2 
treatment, determined by 8-OHdG staining, was not reduced following incubation with 
HSPCs for 24hr but was significantly (p<0.05) reduced by 72hr (Fig.7A). H2O2 driven ROS 
generation, measured by DHE staining, was also reduced at 72hr (p<0.001) following 
incubation with HSPCs (Fig.7B&C).   
HSPCs significantly decreased serum levels of multiple pro-inflammatory cytokines 
but increased levels of IL-10 
IRI induced a significant (p<0.05) increase in the circulating serum levels of 10 out of 23 
inflammatory cyokines tested (Table 1).  Greater than 6-fold increases were observed in IL-
6, IL-12, G-CSF, KC, MCP-1 and MIP-1 levels.  HSPCs reduced the serum concentration 
of 9 of these factors as well as some cytokines whose increase post-IRI was not significantly 
increased.  Interestingly, HSPCs significantly (p<0.01) increased the serum levels of IL-10.  
 
 
DISCUSSION 
 
Adequate microcirculatory perfusion, and not just opening of an occluded epicardial artery, is 
critical in order to salvage myocardial tissue post-MI.  However, the pathophysiological 
changes in coronary microvascular perfusion taking place following an ischaemic insult have 
not previously been imaged directly. Here, we present a novel approach to image multiple 
coronary microcirculatory perturbations intravitally in a stabilised beating mouse heart with 
assessment of overall blood flow using laser speckle imaging.  A sustained ventricular 
hyperaemic response was noted throughout reperfusion.  On its own, this could have been 
interpreted as blood flow being adequately re-established to repay the debt acquired during 
ischaemia.  However, it was clear from intravital studies that this was poorly transmitted to 
coronary capillaries and thus did not correspond to adequate perfusion at a microvascular 
level.    
Neutrophil adhesion increased rapidly in injured hearts, doubling by 30mins post-
reperfusion.  Neutrophil capture is generally confined to post-capillary venules due to their 
high and preferential expression of endothelial adhesion molecules.22 In the heart, we noted 
neutrophil retention mainly within capillaries, a region of the vasculature not usually 
associated with cellular recruitment.  VCAM-1 expression was also increased in IRI 
vasculature.  However, unlike in previously published work,23 this was observed on 
capillaries as well as larger vessels.  This suggests active capture mechanisms may also be 
involved in mediating capillary-neutrophil interactions in the heart.  Neutrophil accumulation 
has long been recognized histologically as a significant component of myocardial IRI.  
However, the impact of their sequestration on coronary perfusion has not been possible to 
determine from static sections. Intravitally, we show that obstructions in microvessel blood 
flow do not generally occur in areas with individual adherent neutrophils.  This was 
evidenced by the fact that FCD did not decrease in the whole field of view in parallel with the 
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diffuse neutrophil adhesion.  Indeed, only distinct patchy areas lacking FITC-BSA perfusion 
were observed.   
Interestingly, a significant population of adherent neutrophils were observed in sham hearts 
in vivo.  This was unusual based on our extensive intravital experience of imaging other solid 
organs.15-19 Adhesion many have been stimulated by attaching the stabiliser but this is 
unlikely as they this population was present even in non-stabilised hearts.  We speculate 
that some trafficking neutrophils may have become trapped as blood vessels were 
compressed during systole. Extravascular compression during isovolumetric contraction 
markedly reduces coronary flow.24-26 Indeed, LSCI clearly identified decreased myocardial 
blood flow during systole.  As far as we are aware, this is the first application of LSCI to the 
beating mouse ventricle and demonstration of real-time phasic changes associated with the 
cardiac cycle.  Interestingly, adherent neutrophils did not obstruct blood flow as evidenced 
by the ease and ability of FITC-BSA to permeate through the sham heart microvasculature.   
Numbers of free-flowing neutrophils circulating through the injured heart also doubled 
throughout reperfusion.  This is an interesting observation, particularly in light of the fact that 
the density of FITC-BSA perfused capillaries decreased.  Higher numbers of circulating 
neutrophils passing through less microvasculature can be explained by a possible increase 
in the blood flow to the injured heart.  Indeed, this is supported by the LSCI data.  Reactive 
hyperaemic responses post-occlusion benefit the oxygen-deprived myocardium.  However, 
these responses also inadvertently introduce more inflammatory cells into an environment 
primed for their adhesion.   
We also occasionally observed neutrophils, in both sham and injured hearts, that appeared 
to slowly „patrol' short lengths of the capillary.  This patrolling behaviour is novel in the heart 
and the physiological relevance is unclear in sham mice, but following IRI it may possibly 
reflect attempts to identify emigration sites.  Recent intravital imaging provides evidence that 
neutrophils also constitutively patrol glomerular capillaries and following injury exhibit a 
greater dwell time and increased ROS generation.27 „Crawling‟ neutrophils, seeking to 
provide the first line of defense against infection, have also been identified in pulmonary 
capillaries.28  Collectively, these studies provide insights into a new neutrophil behaviour that 
does not appear to be site-specific. 
Although individual platelet adhesion was enhanced, it was the formation and sustained 
elevated presence of platelet aggregates that was a striking feature in reperfused hearts.  
Numerous small, rounded aggregates were seen as well as larger, elongated microthrombi 
occupying significant lengths of the capillaries. The major consequence of these was the 
detrimental effect on capillary perfusion in their immediate vicinity.  This was demonstrated 
by the lack of FITC-BSA presence downstream of microthrombi.  Hence multiple non-
perfused areas were identified interspersed with perfused microvasculature.  Although it is 
often suggested that platelet microaggregates impede microvascular flow following MI29-30, 
our studies provide the first direct in vivo evidence of their occlusive nature in an IR injured 
beating heart.   
A marked but transient increase in blood delivery to the heart following ischaemia, lasting 
only a few minutes, has been demonstrated both experimentally and clinically.31-32 Indeed in 
humans, coronary blood flow can increase up to five times basal flow to meet increased 
demand following release of a variety of vasodilatory factors.31  Interestingly, in the current 
study a more sustained reactive hyperaemic response was identified. This discrepancy may 
possibly be explained by technical differences. Previously, blood flow responses were 
measured from one of the major coronary arteries using an inserted Doppler flow guide wire.  
However, in the current study, the full-field optical nature of LSCI was able to image a larger 
ventricular area, thus averaging macro- and microvascular flow changes, over longer periods 
of time.  
Although individual neutrophils did not appear to hinder flow, their increased presence is 
detrimental. Since activated neutrophils generate ROS, their rapid and high capillary 
presence increases the susceptibility of these delicate structures to early and significant 
D
ow
nloaded from
 https://academ
ic.oup.com
/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvz118/5486400 by U
niversity of Birm
ingham
 user on 08 M
ay 2019
10 
 
oxidative damage. Indeed, flow cytometry data demonstrated coronary endothelium, rather 
than myocytes, was the primary and initial target of oxidative injury. Furthermore, a high 
degree of correlation between capillary CD31 and 8-OHdG immunostaining was noted 
histologically.  Others have also shown this differential susceptibility to injury with endothelial 
and cardiomyocyte apoptotic death occurring at 5 and 60mins respectively in isolated 
perfused hearts.33-34 Collectively, this data highlights coronary microcirculation as an early 
and principal therapeutic target to prevent ensuing muscle damage. 
Our model was therefore used for the first time to image stem cell trafficking in vivo at a 
cellular level and, importantly, ascertain whether vasculoprotection was a critical therapeutic 
mechanism.  We focussed on cellular therapy as there has been intense interest in their use 
for cardiovascular diseases.  Even through the field has progressed rapidly to clinical trials, it 
is agreed that more basic research is required to understand their mechanisms of action and 
thus improve on their modest clinical success.  Although clinical studies have primarily used 
total un-fractionated BM mononuclear cells (comprising HSPCs, mesenchymal stem cells 
(MSCs), lymphocytes and monocytes), we focused on a purified population of HSPCs.  A 4-
fold increase in circulating HSPCs was identified in IRI hearts, which may be related to the 
hyperaemic response. However, 25-30 circulating cells were consistently observed 
throughout reperfusion. This was unusual as we have shown in other organs that HSPCs 
were only observed on the „first pass‟ immediately after infusion and not thereafter.16-18,20 
Surprisingly, these homing events did not result in any dramatic local HSPC retention, which 
remained low and similar to sham hearts.  Furthermore, pre-treatment strategies did not 
modify their adhesion.  Poor retention is a well described phenomenon. For example, 
Hoffman and colleagues demonstrated <2.6% retention of unselected BM-derived cells in 
STEMI patients when delivered 5-10 days after stenting.35  Pulmonary entrapment is a 
common feature of cellular therapy36-37 which we also noted in the current study. 
This observation was potentially troublesome, as the efficacy of cellular therapy has been 
thought to be dependent on sufficient retention within injury sites.38  Indeed, a recent study 
demonstrated that developing platelet-based strategies to improve the targeted delivery of 
peripheral blood mononuclear cells to the IRI heart led to reduced infiltration of inflammatory 
cells, reduced fibrosis and enhanced capillary density after IR injury.39  However, we showed 
that despite limited local retention, HSPCs afforded rapid and remarkable vasculoprotection 
in the injured heart, limiting both neutrophil and platelet adhesion and thus improving FCD.  
BM-derived stem and progenitor cells can secrete a rich and potent combination of growth 
factors and anti-inflammatory cytokines that act in a paracrine manner on neighbouring 
cells.40-41 Even without retention in the heart, these factors may be released systemically 
from remote sites and confer vasculoprotection in the heart.36  Indeed, remote 
transplantation of MSCs into the interscapular region protected the IRI heart.42  Since 
HSPCs continuously circulated through the heart, it is also possible they became activated 
to release paracrine factors locally as they trafficked through the injured coronary 
microcirculation. HSPCs inhibited both a number of pro-inflammtory cytokines as well as 
ICAM-1/VCAM-1 up-regulation, which could mechanistically explain the decreased 
neutrophil infiltration.  Interestingly, we show that HSPCs also induced a significant increase 
in circulating IL-10 levels in IRI mice.  IL-10 is a naturally occurring, potent anti-inflammatory 
cytokine which can suppress secretion of various pro-inflammatory cytokines both in vitro and in vivo 
via inhibition of NF-κβ.
43   A number of immunohistochemical studies have demonstrated that 
exogenous IL-10 can suppress myocardial inflammation as evidenced by decreased 
neutrophil infiltration in similar injury models.44-45  Indeed, the beneficial effects of remote 
ischaemic pre-conditioning in the heart have also been demonstrated to be mediated via 
increases in IL-10.46  Furthermore, genetically engineering mesenchymal stem cells (MSC) 
to overexpress IL-10 has been shown to better reduce infarct size and cardiac impairment 
compared to individual treatments of MSC or IL-10 administration 47  It is therefore likely that 
increased serum levels of IL-10 in mice receiving HSPCs mechanistically explains the 
vasculoprotective effects observed in the current study.   
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The impact on platelet activity is somewhat harder to explain.  It is possible that platelet 
aggregation occurred subsequent to endothelial damage and denudation instigated by 
neutrophils. However, since both thrombotic and inflammatory events had already occurred 
by the earliest imaging time point, it is not clear which cellular event occurred first.  
Alternatively, HSPCs may possess direct anti-thrombotic potency.  Indeed, this was recently 
described for MSCs in the lungs and was linked to modification of urokinase-type 
plasminogen activator, a protein important in early thrombi resolution.48-49  Whether HSPCs 
modify this pathway is not known and would require further examination.  The only event not 
influenced by HSPCs was hyperaemia, which is perhaps not surprising, as this is a reactive 
response to ischaemia which was induced in all experimental groups including mice 
receiving cellular therapy. 
Spinning disk confocal allowed for high resolution and real-time capture of dynamic images 
of the beating heart that would not have been possible with conventional single laser raster 
scanning microscopy.  However, the imaging is relatively „superficial‟ with an imaging depth 
of 25-35μm beneath the heart surface.  Theoretically, confocal imaging could have 
delivered signals from more depth.  However, our low exposure times, required for video-
rate imaging of coronary microvessels, limited imaging depth.  Greater depth could be 
achieved with multiphoton microscopy.  However, our initial attempts using multiphoton 
intravital microscopy (Olympus Fluoview) have been challenging due to residual movement 
that remains even after stabilisation (unpublished data) and additional methodological 
enhancements are required such as respiratory/cardiac gating.  Even so, we find imaging 
depth in the heart to be modestly increased to 70-80μm.  To appreciate the global effects of 
myocardial IRI on the coronary microcirculation throughout the muscle wall, multiphoton 
imaging on tissue sections spanning the full thickness of the ventricular wall is required.   
To summarise, intravital imaging of the beating mouse heart, combined with laser speckle 
microscopy, provides a wealth of dynamic information on the coronary microcirculation that 
is not possible to obtain with conventional immunohistological approaches. We show for the 
first time that although IRI is associated with an overall hyperaemic response in the injured 
ventricle, this may be deceptive as at a microvascular level, increased flow heterogeneity 
exists due to occluded coronary capillaries.  Hence there exists a great mismatch between a 
"global hyperaemic response" during reperfusion, and microcirculatory heterogeneity. To the 
best of our knowledge, this is the first detailed in vivo characterisation of multiple 
microcirculatory perturbations taking place in the IR injured beating heart.  Although Li and 
colleagues have also intravitally imaged a beating mouse heart, they imaged a donor heart 
transplanted in the neck of the recipient, with a focus on neutrophil kinetics.15  Crucially, our 
research is conducted on the native heart in situ which has greater clinical relevance as an 
experimental model for MI.  We further show that local stem cell presence is not a pre-
requisite to preventing myocardial thromboinflammatory events. Since acellular delivery of 
stem cell-derived paracrine factors may be sufficient to activate repair mechanisms, this 
should be tested in our model and is indeed the basis of future studies.  It is anticipated that 
this model will have a number of future applications.  For example, microvascular 
dysfunction is a key feature of cardiovascular disease in females, with both cardiac 
syndrome X and MINOCA being more common in women.  Applying our beating heart 
intravital imaging method to female mice would be a worthwhile pursuit to assess sex related 
differences in the microcirculatory responses to IR injury.    
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Table 
 
 
Table 1.  HSPCs reduce serum concentration of multiple pro-inflammatory factors but 
increase sreum levels of IL-10, a known anti-inflammatory cytokine.  IRI induced a 
significant increase in the circulating serum levels of 10 out of 23 inflammatory cyokines 
tested using a Luminex cytokine array kit.  Greater than 6-fold increases were observed in 
IL-6, IL-12, G-CSF, KC, MCP-1 and MIP-1 levels. HSPCs reduced the serum concentration 
of 9 of these factors as well as some cytokines whose increase post-IRI was not significantly 
increased. HSPC administration significantly (p<0.01) increased the serum levels of 
interleukin-10. *† p<0.05, **†† p<0.01, ***††† p<0.001;  Sham vs IR injury or IR injury with 
HSPCs. One-tailed students t-test, n>9 
  
 
Cytokine 
 
 
Sham – pg/ml 
 
IR injury – pg/ml 
 
IR injury + HSCs – pg/ml 
    
Interleukin-1α 14.07 ± 2.90 18.62 ± 3.95 10.63 ± 0.67  
Interleukin-1 37.18 ± 5.06 42.84 ± 4.37 24.94 ± 2.40  
Interleukin-2 14.92 ± 3.00 11.65 ± 0.86 8.17 ± 0.48  
Interleukin-3 17.13 ± 2.45 16.46 ± 1.67 10.93 ± 0.93  
Interleukin-4 13.61 ± 3.48 10.27 ± 2.77 6.76 ± 4.29 
Interleukin-5 32.63 ± 11.95 31.56 ± 5.69 17.78 ± 2.91  
Interleukin-6 316.138 ± 118.21 1993.53 ± 841.45 * 425.07 ± 78.19  
Interleukin-9 51.29 ± 7.54 45.76 ± 4.83 34.22 ± 2.64  
Interleukin-10 143.57 ± 9.06 222.70 ± 45.84 * 452.48 ± 41.06   
Interleukin-12(p40) 2253.75 ± 350.50 14588.86 ± 5889.30 * 2424.66 ± 179.39  
Interleukin-12(p70) 501.84 ± 85.43 555.36 ± 57.31 350.24 ± 38.07  
Interleukin-13 278.182 ± 51.10 337.87 ± 38.67 159.26 ±25.87  
Interleukin-17 18.70 ± 2.68 14.50 ± 1.22 11.36 ± 1.06  
Eotaxin 992.67 ± 113.83 1607.58 ± 50.43 * 1020.15 ± 90.44  
G-CSF 395.23 ± 97.79 2720.72 ± 1272.80 * 200.29 ± 36.04  
GM-CSF 54.52 ± 7.25 61.95 ± 6.50 41.09 ± 4.75  
IFN 46.44 ± 7.28 42.25 ± 4.50 30.55 ± 2.20  
KC (IL-8) 326.15 ± 93.22 1769.48 ± 783.47 * 227.52 ± 28.93  
MCP-1 638.92 ± 121.67 5016.62 ± 2117.35 * 704.97 ± 93.02  
MIP-1α 21.84 ± 8.95 48.51 ± 21.69 37.30 ± 10.35 
MIP-1 169.46 ± 56.60 1545.83 ± 736.81 * 250.28 ± 58.80  
RANTES 108.06 ± 15.03 248.96 ± 79.09 * 85.75 ± 10.29  
TNFα 191.95 ± 29.16  369.49 ± 95.21 * 154.62 ± 19.28  
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Figure Legends 
Figure 1. Neutrophil recruitment and microthrombus formation increases rapidly 
following myocardial IRI.  (A) Free flowing neutrophil number does not increase following 
IRI when compared to sham controls (n=5/group). (B) Neutrophil adhesion within sham 
hearts is high but increases following IRI (****p<0.0001 IR vs Sham with significant 
differences at all time pionts; n=5/group). (C) Free flowing donor platetets transitting through 
myocardium is not increased following IRI (n=5/group).  (D) Singular donor platelet adhesion 
increases across the imaging period following IRI (**p<0.01 IR vs Sham; n=5/group). (E) 
Accumulation of endogeous platelets, appearing as platelet aggregates and microthrombi 
increases following IRI and is quantitated as integrated fluorescence density (***p<0.001 IR 
vs Sham with significant differences at all time points; n=5/group). 2-way ANOVA with 
Sidak‟s multiple comparison test used for all analyisis.  (F) Representative intravital images 
of the beating mouse heart to show rapid accumulation and gradual increases of both 
neutrophils and platelets.  Neutrophils present primarily as individual cells with platelets 
found as aggregates or microthrombi.  Merged images show aggregates comprised of both 
cell types (yellow). Green: Neutrophils (PE+anti-Gr-1ab); Red: endogenous platelets 
(APC+anti-CD41ab).  Scale bars represent 100µm.   
 
Figure 2. Neutrophils adherent within sham hearts do not prevent blood flow – platelet 
aggregates main contributors to occlusive events in IRI. (A) Blurry and out-of-focus 
intravital images obtained from „non-stabilised‟ hearts, but  still showing adherent neutrophils 
in sham myocardial microcirculation.  Better quality and easily quantifiable intravital images 
obtained following stabilisation, which confirm neutrophil adhesion in beating sham hearts. 
(B) Adherent neutrophils in sham hearts do not compromise blood flow as widespread FITC-
BSA perfused capillaries are visible. Green: neutrophils (PE+anti-Gr-1ab); Red: FITC-BSA. 
(C) IRI increases neutrophil adhesion, most of which are singular, although aggregates also 
identified.  (D)  Blood flow compromised in IRI hearts as evidenced by not all capillaries 
being filled with FITC-BSA.  This did not always correspond to areas of neutrophil adhesion. 
Some capillaries „finish‟ abruptly (arrowhead; out-of-focus large vessel seen in this field of 
view).  Magnified image (right) shows neutrophils often adherent or trapped within platelet 
microthrombi in injured hearts, as indicated by co-staining, to form large occlusive 
aggregates.  These impact detrimentally on blood flow as indicated by inability of FITC-BSA 
(red) to perfuse into capillaries (*) downstream of microthrombus (blue/green - circle) 
comprised of platelets (blue) and neutrophils (green). (E)  Neutrophil adhesion, platelet 
aggregation and microthrombus formation following IRI.  Microthrombi occupy and follow the 
contours of a significant length of the capillary (*).  Co-localisation (yellow) indicates 
aggregates are often, but not always, comprised of both neutrophils and platelets. Green: 
neutrophils (PE+anti-Gr-1ab); Red:  endogenous platelets (APC+anti-CD41ab).   (F) Time-
lapse images from an IRI beating heart video.  From left to right, within the white circles, a 
single circulating neutrophil (green, N) is shown unable to move down the capillary as it is 
occluded by a downstream stationary platelet thrombus (red, t). * = circulating neutrophils 
seen in one frame but not the next.  (G)  Time lapse images from a sham beating heart 
showing a „patrolling‟ neutrophil. Dotted lines - track movement of „patrolling‟ neutrophil.  
Scale bars represent 100m 
Figure 3. Myocardial IRI is associated with significantly impaired capillary perfusion 
and a disturbed microvascular organisation. FITC-BSA was administered 2hrs post-
reperfusion and representative intravital images are shown.  (A) In sham mice, an extensive 
network of FITC-BSA perfused capillaries can be observed.  Most capillaries parallel the 
arrangement of the muscle fibres with cross connections that run obliquely to fibres along 
their length.  Although the stabiliser is attached to avoid visible large coronary arteries, well 
perfused medium-sized vessels can be seen in some fields of view (out of focus in some of 
the images). (B) IRI is associated with multiple areas in which FITC-BSA does not perfuse, 
resulting in visualisation of patchy areas devoid of any vasculature (*).  In some fields of 
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view, at least half the imaged area appears non-perfused. The organised parallel 
arrangement of capillaries is lost with microvasculature appearing „disorganised‟. 
Accumulation of FITC-BSA, identified as wider areas of intense fluorescence, occasionally 
seen along the length of some capillaries (arrowheads).  Interestingly, medium sized vessels 
are still perfused and thus readily visible.  Scale bars represent 100µm. 
 
Figure 4.  Despite poor HSPC retention within IRI hearts, vasculoprotective effects are 
identified.  (A) 20-30 free flowing HSPCs observed circulating through myocardial 
microvessels at all time points in sham mice.  However, in IRI hearts, an almost 4-fold 
increase is noted at 30mins post-reperfusion.  Pre-treatment of HSPCs with H2O2 does not 
enhance their homing to injured heart.  (B)  Adhesion of naïve or pre-treated HSPCs is not 
increased as a result of injury but gradually rises in all groups.  (C) Representative intravital 
images shows a similar retention of intra-arterially injected exogenous CFSE-labelled 
HSPCs in all groups.  (D) HSPCs do not affect the free flow of neutrophils through the 
injured heart but do decrease (E) neutrophil adhesion (****p<0.0001 vs IR with significant 
differences at all timepoints; n≥4). (F) Presence of platelet aggregates and microthrombi is 
also significantly reduced (***p<0.001 vs IR with significant differences at all timepoints; 
n≥4). 2-way ANOVA with Sidak‟s multiple comparison test used for all analyisis. (G) 
Representative intravital images of injured heart showing a reduction in endogenous 
neutrophils and platelet presence when compared non-treated injured hearts.  Green: 
neutrophil (PE+anti-Gr-1ab); Red: endogenous platelets (APC+anti-CD41ab). (H) 
Improvement in capillary perfusion subsequent to cellular therapy as determined using FITC-
BSA.  Scale bars represent 100µm. 
 
Figure 5. Laser speckle contrast imaging (LSCI) reveals a sustained reactive 
myocardial hyperaemia in response to IRI. (A) Photos of the beating mouse heart are 
shown alongside the corresponding full field LSCI flux heat map.   All flux images have been 
normalised on the same palette settings.  Pre-ischaemia hearts are well perfused as 
indicated by a more yellow/red heat map.  As expected, flow is reduced in the ischemic heart 
resulting in heat maps that are primarily blue.  Reperfusion induces a rapid and striking 
hyperaemic response as indicated by mostly red heat maps. Analysis graphs from SpAN 
rendered data show diastolic and systolic events captured as high points (green circles) and 
low points respectively. In these representative analysis graphs, arbitrary flux values 
decrease from 1700 to 1400 as a result of ischaemia and increase to 2000 after 
reperfusion.  (B) This raw data has been presented as mean normalised flow flux.  In sham 
mice, ventricular blood flux does not change throughout the course of imaging. Ischaemia 
decreases this value.  Reperfusion induces a rapid and sustained reactive hyperaemic 
response.  The presence of HSpCs in IRI mice produces flux recordings statistically different 
to sham hearts but no different to IRI hearts not receiving HSPCs. ****p<0.0001, +p<0.05; 
ANOVA with Sidak‟s multiple comparison test; n=3/group. 
 
Figure 6. Myocardial endothelial cells are more susceptible than myocytes to 
oxidative stress following acute IRI but this injury can be reduced by HSPCs.  (A) Flow 
cytometric gating strategy used for identifying oxidatively damaged (8-OHdG+) ECs (CD31+ ; 
left) and myocytes (cTnT+ ; right) in digested whole hearts.  (B) Percentage of each cell type 
obtained from a total of 30,000 events.  A greater yield of myocytes is obtained (n=5; 
IR+HSPC groups n=4). (C) Endothelial ICAM-1 expression increases during ischaemia and 
further during reperfusion.  This is reduced by HSPCs injected at the onset of reperfusion 
(*p<0.05 **p<0.01 vs sham;  +p<0.05 vs IR; Sidak; n=3).  (D) Endothelial VCAM-1 expression 
does not increase during ischaemia but non-significantly increases during reperfusion.  This 
is also reduced following HSPC administration (Sidak; n=3). (E) IRI, but not ischaemia alone, 
results in a significant endothelial oxidative damage which is reduced with HSPCs (**p<0.01 
vs sham; #p<0.05 vs IR; Sidak; sham and ischaemia groups n=5;  IR and IR+HSPC groups 
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n=4). (F)  Oxidative damage in myocytes also increases but not to levels seen in 
endothelium (Sidak; n=5; IR+HSPC group n=4).  
 
Figure 7.  Microvascular endothelial oxidative stress can be reduced in VCECs in the 
presence of HSPCs in vitro.  (A) Oxidative damage incurred by H2O2 treated vena cava 
endothelium is reduced following incubation with HSPCs for 72 hr (*p<0.05; n=4; t-test). 
(B&C) H2O2 driven ROS generation, measured by DHE staining, is reduced by HSPCs at 
72hr (***p<0.001; n=3; t-test).  Red = DHE stain; Yellow = CFSE-labelled HSPCs. Scale bars 
represent 100m 
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